In this setting, KRT81 could be a useful novel marker for the differential diagnosis of NSCLC; as such, it could be added to the panel of immunohistochemical markers currently used, such as TTF1 and P63 [42], [43]. This evidence concerns the gene KRT81 and non-small cell lung carcinoma.